Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma.

ABSTRACT:

SUBMITTER: Jain T 

PROVIDER: S-EPMC8224498 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature